End-of-life trajectories of patients with haematological malignancies and advanced solid tumours 77 Table 1. Characteristics of 78 patients with a haematological malignancy and 420 patients with a solid tumour visiting the emergency department. (continued) Characteristics Total n=498 HM-patients n=78 ST-patients n=420 n (%) n (%) n (%) P-value PCCT consulted during last 3 months 27 (5.4) 1 (1.3) 26 (6.2) 0.100 Proactive symptom-management plan in the prior 6 weeks 62 (12.4) 11 (14.1) 51 (12.1) 0.612 Number of ED-visits during the last 6 months, median (range) 1 (0-9) 1 (0-9) 1 (0-7) 0.147 Patient had a family caregiver 0.608 Yes 433 (86.9) 67 (85.9) 366 (87.1) No 31 (6.2) 6 (7.7) 25 (6.0) Unknown 34 (6.8) 5 (6.4) 29 (6.9) Patient had homecare before the ED visit 0.462 Yes 110 (22.1) 19 (24.4) 91 (21.7) No 280 (56.2) 44 (56.4) 236 (56.2) Unknown 108 (21.7) 15 (19.2) 93 (22.1) Living situation 0.120 Alone 90 (18.1) 10 (12.8) 80 (19.0) With someone 369 (74.1) 65 (83.3) 304 (72.4) Unknown 39 (7.8) 3 (3.8) 36 (8.6) Housing 0.075 Home 447 (89.8) 66 (84.6) 381 (90.7) Residential home 9 (1.8) 2 (2.6) 7 (1.7) Nursing home 18 (3.6) 6 (7.7) 12 (2.9) Hospice 6 (1.2) 1 (1.3) 5 (1.2) Other 5 (1.0) 2 (2.6) 3 (0.7) Unknown 13 (2.6) 1 (1.2) 12 (2.9) ECOG-performance score 0.078 0-2 90 (18.1) 17 (21.8) 73 (17.4) 3-4 173 (34.7) 50 (64.1) 123 (29.3) Unknown 235 (47.2) 11 (14.1) 224 (53.3) List of abbreviations: ED: emergency department; HM: haematological malignancy; ST: solid tumour; IQrange: interquartile range; LSTs: life-sustaining treatments; PCCT: palliative care consultation team; ECOG: Eastern Cooperative Oncology Group. a Numbers may exceed 100% because patients may have received multiple disease-modifying therapies in the past. b Limitations on LSTs were defined as orders on: no resuscitation; no ventilation; and no admission to the intensive care unit. 4
RkJQdWJsaXNoZXIy MTk4NDMw